Accessibility of Treatment Among Women With Opioid Use Disorder: A Brief Review.
addiction psychiatry
health policy and advocacy
opioid use disorders
treatment disparity
womens health
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
accepted:
31
07
2022
entrez:
5
9
2022
pubmed:
6
9
2022
medline:
6
9
2022
Statut:
epublish
Résumé
Opioid-use disorder (OUD) has become a social pandemic with a rising incidence and prevalence among women. Notably, women with OUD were more likely to have psychiatric comorbidities like major depressive disorder, anxiety disorder, and bipolar disorder. Evidence suggests that opioid exposure and subsequent disease among women compared to men is unique and attributable to hormonal estrogen levels. However, there remains a dearth of literature on their ability to access treatment when needed. There is also a gap in the perceived access to women as compared to men. Hence, our review will focus on factors that may affect women from seeking OUD treatment as compared to men.
Identifiants
pubmed: 36060319
doi: 10.7759/cureus.27509
pmc: PMC9426717
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e27509Informations de copyright
Copyright © 2022, Khan et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Subst Use Misuse. 2016;51(3):295-309
pubmed: 26872763
Addict Sci Clin Pract. 2022 Mar 7;17(1):16
pubmed: 35255965
Curr Opin HIV AIDS. 2012 Jul;7(4):326-31
pubmed: 22498480
Addict Sci Clin Pract. 2018 May 7;13(1):15
pubmed: 29730987
J Stud Alcohol Drugs. 2020 Jan;81(1):68-73
pubmed: 32048603
Ann Ist Super Sanita. 2016 Apr-Jun;52(2):184-9
pubmed: 27364392
Drug Alcohol Depend. 2021 Apr 1;221:108627
pubmed: 33621805
J Addict Med. 2020 Dec;14(6):502-509
pubmed: 32371659
MMWR Morb Mortal Wkly Rep. 2019 Jan 11;68(1):1-5
pubmed: 30629574
Drug Alcohol Depend. 2017 Oct 1;179:271-274
pubmed: 28823834
Drugs (Abingdon Engl). 2021;28(4):328-339
pubmed: 34321719
F1000Res. 2016 May 13;5:
pubmed: 27239283
Ann Fam Med. 2015 Jan-Feb;13(1):23-6
pubmed: 25583888
Curr Obstet Gynecol Rep. 2016;5:257-263
pubmed: 27563497
Addict Biol. 2020 Jan;25(1):e12680
pubmed: 30295400
Obstet Gynecol. 2012 May;119(5):1070-6
pubmed: 22525931
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):298-302
pubmed: 32191686
Prehosp Emerg Care. 2016;20(2):220-5
pubmed: 26383533
Clin Ther. 2018 Feb;40(2):190-196
pubmed: 29329750
JAMA Netw Open. 2020 Aug 3;3(8):e2013456
pubmed: 32797175
Psychol Addict Behav. 2004 Jun;18(2):180-3
pubmed: 15238060
Harm Reduct J. 2020 Jan 9;17(1):4
pubmed: 31918740
Drug Alcohol Depend. 2019 Dec 1;205:107652
pubmed: 31704383
Drug Alcohol Depend. 2018 Jul 01;188:328-333
pubmed: 29852450
J Subst Abuse Treat. 2018 Oct;93:31-37
pubmed: 30126539
Subst Abus. 2021;42(2):197-204
pubmed: 31638868
Curr Opin Obstet Gynecol. 2019 Apr;31(2):83-89
pubmed: 30789842
J Cell Mol Med. 2017 Dec;21(12):3552-3564
pubmed: 28699698
Clin Psychol Rev. 2015 Jul;39:71-82
pubmed: 25939033
PLoS One. 2020 May 15;15(5):e0233185
pubmed: 32413081
J Subst Abuse Treat. 2018 Jun;89:75-86
pubmed: 29706176
J Community Health. 2013 Feb;38(1):133-41
pubmed: 22847602
Clin Ther. 2020 Mar;42(3):419-426
pubmed: 32160970
Open Forum Infect Dis. 2021 May 29;8(6):ofab285
pubmed: 34189180
Semin Perinatol. 2019 Apr;43(3):132-140
pubmed: 30981471
Am J Addict. 2018 Sep;27(6):465-470
pubmed: 30106494
J Am Acad Child Adolesc Psychiatry. 2018 Feb;57(2):125-131
pubmed: 29413145